Moneycontrol
HomeNewsBusinessEconomyForeign brokerages see RBI slashing 50-75 bps more by October as inflation seen plunging to 2-2.5%

Foreign brokerages see RBI slashing 50-75 bps more by October as inflation seen plunging to 2-2.5%

UBS has blamed the steep increase in the June retail inflation to the supply-side constraints coupled with costly transport fuels after the government hiked petrol and diesel prices in April.

July 14, 2020 / 18:59 IST
Story continues below Advertisement
File image

Foreign brokerages are betting on aggressive rate cuts by the Reserve Bank -- to the tune of 50-75 bps by October -- as they see retail inflation plunging to 2-2.5 per cent by December as all the fundamentals of the economy are very weak. While Wall Street major Bank of America (BofA) expects the RBI to slash up to 75 bps -- 25 bps on August 6 and another 50 bps in October, if the COVID-19 is brought under control by October. Swiss major UBS sees the central bank slashing 50 bps before the end of the fiscal as it expects inflation to plunge to 2.0-2.5 per cent by December.

At 6.1 per cent, retail inflation in June was much above market expectations of 5.2 per cent. But the number is lower than the previous two months -- at 6.3 per cent in May and still higher 7.2 per cent of April. It is expected to print in at 6.4 per cent in July.

Story continues below Advertisement

"We expect inflation to slip to 2.5 per cent in the second half of the fiscal,” BofA said in a note citing the “very weak fundamental drivers” of the economy such as a contracting GDP, tight money supply, good rains, limited imported inflation and limited fiscal slippage.

Therefore, “we see the RBI cutting 25 bps on August 5, and 50 bps in the October review, assuming that the lockdown ends in mid-September and restart takes off from October", BofA economists said in a note on Tuesday.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show